DESIGN AND FATIGUE STUDY OF INTRAVASCULAR CORONARY STENT USING
FINITE ELEMENT ANALYSIS

A Thesis
Presented to
the Faculty of the College of Science & Technology
Morehead State University

In Partial Fulfillment
of the Requirements for the Degree
Master of Science

by

Jared May
March 15, 2012

fYISLf

,H£s£g
{,,/7. L/l'J.

/VJ Lf I,, (,, d._
Accepted by the faculty of the College of Science & Technology, Morehead State University, in
partial fulfillment of the requirements for the Master of Science degree.

Master's Committee:

Date

DESIGN AND FATIGUE STUDY OF INTRAVASCULAR CORONARY STENTS USING
FINITE ELEMENT ANALYSIS
Jared May, M.S.
Morehead State Universirx,.....,....,.

(1
Director of Thesis: ,

,-

Fatigue is a material ~ = m a t e r i a l . Fatigue can make the
material fail before the stresses reach ultimate tensile strength or fracture strength. Intravascular
coronary stent are subjected to cyclic loads when placed in vivo. Once in a coronary artery,
stents are loaded with systolic and diastolic pulse pressures. The purposes of this research
entitled Design and Fatigue Study ofIntravascular Coronary Stents Using Finite Element
Analysis will study the impact of cyclic load on various stent geometries. This research will also

parametrically design a coronary stent that will provide comparable fatigue life to commercially
available stent designs. SolidWorks design software will be used to create three dimensional
geometries of the stents as well as parametrically design a stent. Abaqus finite element analysis
software will be used to simulate in vivo artery conditions. It will also be used to crimp the stent
models and then deploy them within the artery. The stent fatigue will be analyzed using
modified Goodman failure criteria. Each of the stent geometries will be tested using a variety of
materials. These materials include 316L stainless steel, nitinol, and poly-L-lactic acid. An
analysis of variance will determine if stent geometry, material, or a combination of the two have
the greatest impact on fatigue life.
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Chapter One
Introduction
Disease associated with the buildup of atherosclerotic plaque in the coronary
arteries has a high mortality rate in the Western world. The most common of these
diseases is coronary artery disease. Coronary artery disease is the deadliest disease in
the United States (Lim, 2004). In 2005, a total of 445,687 people died due to
complications associated with coronary artery disease (Centers for Disease Control
and Prevention, 2010).
Traditionally coronary artery complications are treated using coronary bypass
procedures. Bypass procedures are an open surgery in which the chest cavity is
opened for the procedure. The heart is also opened during this surgery. The
offending artery is removed and replaced with a graft. Coronary bypass procedures
are extremely invasive. A surgery of this complicated nature can lead to
complications such as infection, immunological graft rejection, etc.
Contemporary procedures involve placing an implant known as a stent in the
offending artery. A stent acts as a scaffolding structure that holds and compresses the
atherosclerotic plaque and reopens the diseased artery. The stenting procedure is
considered to be a minimally invasive procedure when compared to the invasive
coronary bypass procedure. The stent is placed on a guide wire system that
maneuvers the stent through the body. An opening is made in the femoral artery (the
artery located along the thigh). The stent system is then guided through the opening
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and along the arterial tree to the diseased artery. Stents are currently being
manufactured from various materials including metals and polymers. Coronary
stenting provides an attractive alternative to coronary bypass. A coronary
intervention is needed due to a complication known as stenosis. Stenosis is
associated with the closure of an artery due to a buildup of atherosclerotic plaque.
However, stenting is not without complications. The risks that generate the most
concern are restenosis and stent failure. Restenosis is a vascular phenomenon that is
caused by complications due to the stenting procedure. It can lead to an arterial
blockage similar to that caused by the initial stenosis. Restenosis can occur for a
variety of reasons. Restenosis can occur when the stent imposes a high level of shear
stresses on the arterial wall. These shear stresses occur where the stent makes contact
with the artery. Shear stress can cause the arterial wall to tear. The body will then
attempt to repair the arterial tear by adding layers of smooth muscle tissue to the
artery. The smooth muscle tissue can accumulate over time and reclose the artery
(i.e. restenosis ).
Another concern with coronary stents is mechanical failure. Stents are
subjected to cyclic pressures associated with the systolic and diastolic pressures of the
heartbeat. Any cyclic load can lead to fatigue in the stent's material. Fatigue can
lead to premature material failure in the stent and be a prominent cause in restenosis.
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Research Objectives
The objective of this research is to perform a fatigue analysis on various
commercially available stent geometries using finite element analysis. The stents will
be tested using a combination of various biologically accepted materials. The
objective will be to determine the fatigue life of these commercial stent utilizing these
biologically accepted materials. The materials tested will include 316L stainless
steel, Nitinol, and poly-L-lactic acid. A statistical analysis will be performed to
determine if material is a significant determinant in fatigue life.

Limitations
This research will not take drug eluting stents into account. Drug eluting
stents are stents that releases small doses of medication such as paclitaxel. Drug
eluting stents help to limit the occurrence of a blood clot, or arterial thrombosis.
Thrombosis can cause restenosis due to a blood clot that forms and blood flow
stagnation around the stent. Therefore, thrombosis is not considered in the research
as well.
Hemodynamics will not be considered. Hemodynamics is the study of blood
flow through the artery.
The balloon interaction with the stent will not be taken into account. The
balloon's interaction with the stent does not significantly contribute to the fatigue life
of the stent.

4

Assumptions
The atherosclerotic plaque will be considered to be symmetrically distributed
along the circumference of the artery. The artery will be modeled to represent a
concentric plaque.
It will be assumed that the patient whose artery will be modeled has no
genetic predisposition to diabetes. Diabetes can change the mechanical properties of
the arterial wall. Diabetes can lead to higher circumferential stress in the artery at
lower strain rates (Fung, 2002).A genetic predisposition to heart disease can cause an
onset of myocardial infarction at an early age. The patient will be considered to have
a mean age of65.9 years (Ellis & Holmes, 2000). This mean age of65.9 years will
allow for the assumption that the atherosclerotic plaque has accumulated naturally
overtime leading to the eccentric plaque in the aforementioned assumption.

Significance of the Study
Predicting coronary stent failure is an adequate method for determining the
onset of in-stent restenosis. Stents are subjected to cyclic loading once placed in-

vivo. Cyclic loading can lead to stent fatigue (reducing the stent's radial strength) and
material failure. A loss of radial strength can lead to a collapse of the stented artery
and thus restrict blood flow.
This study will analyze the fatigue life of a commercially available stent made
of different materials. The study will determine the significance of stent material and
design when determining fatigue life.
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Definition of Terms
•

Adventitia: the outer most layer of the arterial wall. The adventitia is
comprised of collagen fibers (Hastings, 1992).

•

Atherosclerosis: A physiological phenomena in which the arterial wall
thickens, hardens, and eventually loses its elastic properties (Wang, 2001 ).

•

Coronary Artery: Arteries that supply oxygen rich blood to the heart muscle.

•

Coronary Artery Disease: A plaque buildup in the coronary artery. Coronary
artery disease is often associated with atherosclerosis.

•

Hyperelastic Material: A material in which the derivative of the strain density
equals the stress per unit volume (Mase, 1970).

•

Intima: The inner most layer of the arterial wall. The lumen is made of
endothelial cells (Hastings, 1992). The intima is contacts the blood in a
healthy artery.

•

Lumen: The passageway in the artery in which blood flows.

•

Media: The center layer of the arterial wall. The media determines the arteries
elastic properties. It is made of collagen and elastin fibers. A high
concentration of elastin fibers gives the artery a high elasticity (Hastings,
1992).

•

Myocardium: Heart muscle.

•

Restenosis: A decrease in arterial lumen that is usually associated with
coronary intervention procedures. Restenosis occurs due to arterial elastic
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recoil that can lead to a thickening of the adventitia (Migliavacca, et al.,
2004).

•

Shape Memory Alloy: A material that returns to its original cold worked shape
under the influence of thermal or other mechanical stresses.

•

Stenosis: A reduction of arterial lumen usually due to an atherosclerotic
buildup.
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Chapter Two
Literature Review
In this chapter, an overview of the human coronary artery will be presented.
The formation and types of atherosclerotic plaque will also be presented along with
an overview of the stent procedures. The basic finite element method will be
described in terms of global stiffness matrices. A background study into stent
analysis will also be described.

Artery Overview
The artery is a passageway that transports oxygen rich blood from the
myocardium to the rest of the human body. Coronary arteries provide oxygenated
blood from the lungs to the myocardium. A restriction in the coronary artery can lead
to a decreased blood flow to the myocardium. This blood flow reduction can lead to
myocardial infarction, or heart attack. Myocardial infarction occurs when the heart
muscle does not receive enough oxygen to properly function. The cells in the
myocardium then begin to die due to oxygen starvation.
A healthy artery consists of three layers: the intima, the media, and the
adventitia. Figure 1 illustrates the layers of the arterial wall.
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Figure 1. The layered structure of the arterial wall (Mortier, 2010).
the layers of the artery are composed of two major fibers: elastin and
collagen. Elastin is a non-linear elastic material. It has an incremental Young's
modulus of 3 * 105 Pa at a strain of 40% (Hastings, 1992). Collagen is a stiffer
material possessing a Young's modulus of 10 8 Pa at a strain of3% to 4% (Hastings,
1992). These two fibers act in tandem to give the artery its elastic and structural
properties.
The endothelium is a portion of the intima that contacts the blood. The intima
consists of collagen fibers. The intima is the thinnest layer of the artery and does not
serve a significant role in the artery's structural integrity.
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The media has different compositions throughout the human body. Larger
coronary arteries consist of elastin fibers (Hastings, 1992). These elastin fibers give
larger arteries a high degree of elasticity. Smaller arteries are made up of smooth
muscle as well as a matrix of elastin and collagen. Smaller arteries are less elastic
than their larger counterparts.
The adventitia is exclusively made up of collagen fibers. The adventitia is the arteries
main structural component of the artery.
Arteries are subjected to pre-tensioning stresses in the body which serve .to
tether the artery to the surrounding connective heart tissue. This in-vivo tethering
allows the artery to move in both the radial and longitudinal directions (Hastings,
1992). It is well documented that an artery that is removed from the body will
undergo a significant reduction of length (Green, Schajer, Parker, & Post, 1995). The
artery length can have a reduction of up to 50% the original length. This reduction
indicates an in-vivo arterial pre-tensioning. Therefore, an artery removed from the
body is said to be in a no-load state. Fung proposed that an artery placed in-vitro can
be returned to its in-vivo state by stretching the artery along its central longitudinal
axis (Fung, 2002).
The artery is a complex mechanical structure. The artery does not have a
linear stress and strain relationship. Therefore, it is difficult to determine an exact
Young's modulus for the artery. An incremental Young's modulus can be calculated
using assumptions that the artery is an incompressible and isotropic material. Hasting
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provides means for calculating the incremental Young's modulus for an artery based
upon assumptions of pseudo-elasticity (Hastings, 1992).

MR R}2(1-v2 )
M (R;-R})
0

0

Where:

R 0 is the outer artery radius

R; is the inner artery radius
A R0 is the change in outer radius due to a pressure

M is the change in pressure

vis the Poisson's Ratio
A more accurate view of the artery's elastic nature can also be modeled using
deformable continuum mechanics theory. The artery does not have a linear
stress/strain relationship and can therefore be can be modeled as a hyperelastic solid.
A hyperelastic solid can be defined using a strain density function based upon the
principles stretches of the material. The basic form of the artery's constitutive
equation is shown below (Simulia).

(2)

Where:
r_/ef is the material strain density function

Cij is a material constant (the subscripts i and j describe the direction)

Ii

is the first Cauchy strain invariant
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h is the second Cauchy strain invariant
D 1 is the material compressibility factor
Je1

is material elastic volume strain
The Cauchy stress invariants are defined in terms of the principle stresses.

The first and second Cauchy stress invariants can be defined as follows.
1

(3)

l,=~ +2.4u

(4)

1, =~+2~
2

Where:
" is the principal stretch

Atherosclerosis Formation and Types:
Atherosclerosis formation is a complex biological process that is characterized
by a hardening of the artery due to an increased concentration of smooth muscle cells
in the intimal artery layer (Raines & Ross, 1995). The increased number of smooth
muscle cells causes the intima to thicken.
Normal atherosclerotic growth typically occurs over several decades and can
begin in the infant and toddler years. Atherosclerotic plaque begins as an
inflammation in the endothelium cells of the intima (Ross, 1999). Fatty streaks form
in the arteries during the early stages of life. This fatty streak is associated with an
arterial wall inflammation, thus leading to a slight reduction of the lumen. The
diseased endothelium gains an adhesive property. Lipids then begin to accumulate
around these adhesive fatty streaks as the person ages. The accumulation of lipids
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incites an immunological response in the artery. The artery attempts to recover
through an accumulation of smooth muscle ceJJs. The smooth muscle cells intertwine
with the lipid leading to a complicated atherosclerotic lesion. The artery will then
attempt to recover (Ross, 1999). During the arterial recovery process, the artery wall
thickens. The thickened arterial wall helps to dilate the lumen and keep constant
blood flow. After remodeling, the artery wall will continue to inflame and release
various growth factor enzymes (Ross, 1999). This inflammation process leads to
necrosis in which the artery ceJJs begin to die. Smooth muscle ceJJs begin to
accumulate around the diseased lesion once again. A fibrous cap forms over the
lesion and covers the lipid, smooth muscle, and necrotic core. This is known as a
complicated lesion. Figure 2 illustrates the atherosclerosis accumulation process.

13

NOMANCLA TURE AND
MAIN HISTOLOGY

SEQUENCES IN PROGRESSION
OF ATHEROSCLEROSIS

EARLIEST
ONSET

MAIN GROWTH
CLINICAL
MECHANISM COLLERLA110N

Initial lesion
• hlstologlcally "normal"
• macrophage Infiltration
• Isolated foam cells

from

first
decade

Fatty streak
mainly Intracellular lipid
accumulation

cllnicanv
silent

z

growth
mainlv by
lipid
addition

0

M

tiz

::,

Intermediate lesion
• Intracellular lipid accumulation
• small extracellular lipid pools

"Cl)
►
Q

..,
c(
..,
M

w

from
third
decade

Atheroma
• Intracellular lipid accumulation
• core of extracellular lipid

::c
w
::c
I-

0

Q

zw

Fibroatheroma
• single or multiple llpld cores
• flbrotlc/calclflc layers

from
fourth
decade

Complicated lesion
• surface defect
• hematoma-hemorrhage
• thrombosis

Increased
smooth
muscle
and
collagen
Increase

clinically
silent
or overt

thrombosis
and/ or
hematoma

Figure 2. Atherosclerosis growth and complication (Forensic Medici11e for Medical
Students, 20 I 0).
Myocard ial infarction can then occur when the blood flow induced stresses
rupture the fibrous cap surrounding the les ion. The rupture leads to a blood clot (also
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known as thrombosis). The blood clot reduces the blood flow to the heart, thus
starving it of oxygen. This oxygen starvation leads to necrosis of the myocardium.
There are various components of an atherosclerotic plaque. One such
component of plaque is the calcified plaque. Calcified atherosclerosis is associated
with an aged lesion which tends to possess an increased collagen density similar to
the collagen densities found in bone (Fitzpatrick, Edwards, & Ingram, 1994).
Calcification typically accumulates in the intima layer of the artery. The calcification
leads to intimal thickening and hardening. The arterial calcification process is almost
identical to that process found in the formation of bone. Osteopontitn and osteonectin
have been found in calcified intima layers (Bobryshev, Lord, & Warren, 1995).
Osteopontitn and osteonectin are minerals found in bone formation.
Atherosclerotic plaque also consists of lipids. Lipids consist of crystalline
cholesterol, cholesteryl, and phospholipids (Sirol, 2006). The lipid core of the
atherosclerotic plaque forms through the accumulation of fatty streaks that are rich
with lipid cells (Ross, 1993). Lipid concentration can influence the intensity of the
mechanical stresses within the atherosclerotic plaque. A larger lipid core can lead to
higher stresses within the plaque and artery (Huang, et al., 2001). The lipid
concentration has been known to lead to a structure weakening of the arterial wall
(Guyton & Klemp, 1989). These stresses can then lead to plaque rupture and
myocardial infarction. The lipid core forms between the fibrous cap and the intimal
layer.
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A third component of atherosclerotic plaque is a fibrous cap. The fibrous cap
is made up of smooth muscle tissue, extracellular material (collagen, proglycans, and
elastin fibers) (Sirol, 2006). The· fibrous cap covers the vulnerable lipid core and
necrotic smooth cells (Bennett, 2007). Plaque rupture can occur if the fibrous cap is
thin. The thin fibrous cap acts as a stress concentrator and thus can rupture under
relatively low physiological forces.

Stenting Overview
Over one million stenting procedures are performed worldwide each year
(Kandzari, Tcheng, & Zidar, 2002). Stents act as a scaffolding structure that
compresses the complicated atherosclerotic lesion. Cardiovascular stents are placed
and expanded within the offending artery. The stenting procedure is a minimally
invasive coronary intervention. The procedure involves placing the stent and
deployment balloon on a catheter and guide wire. The stent system is typically
placed in the peripheral artery in the thigh. The stent is then guided through the
cardiovascular tree to the offending artery. Interventional radiology in the form ofxray is used to aid the cardiologist in maneuvering the stent. Once the stent is in place,
it is expanded within the artery.
Stents are traditionally manufacturer from biologically compliant metals.
These metals include 3161 stainless steel, cobalt chromium, and tantalum among
others. Biocompatibility is extremely important when designing a stent. If the stent
material is not biologically compatible, an immunological response can be incited
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with the artery. This immunological response can include arterial trauma such as
inflammation and scarring (Lim, 2004). Other severe immunological reactions
include chronic inflammation and toxin buildup as the immune system attacks the
stent. Any immune system response can lead to thrombosis and in-stent restenosis.
Another potential problem with stents is the complication of restenosis. Stent design
can directly influence restenosis rates. Restenosis is typically associated witl1 the
small, less elastic arteries but can still be a significant risk factor in the elastic
coronary arteries. Studies have shown that stents with thicker struts (greater than
0.10 mm) can cause higher restenosis rates than those stents with thin struts (Briguori,
et al., 2002). Thicker struts can lead to higher stresses in the arterial wall. In-stent
restenosis is primarily an inflammatory response. Restenosis involves neointimal
hyperplasia or intimal remodeling (Komowski, et al., 1998). The stent struts have a
tendency to cause shear stresses along the contact boundary between the stent and
artery. The arterial remodeling involves an accumulation of smootli cells along the
site of the shear stresses (Glagov, 1994). These smooth cells can get accumulated to
the point that the lumen is once again blocked in spite of the stent; hence the in-stent
restenosis phenomenon. Figure 3 demonstrates the basic in-stent restenosis process.
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Drug eluting stents may be another method besides optimized stru t design that
can combat the occurTence of in-stent restcnosis. Drug eluting stents are coated with
antithrombogenic medicines uch as pac litaxel or sirolimus (Poerner, Haase,
Wiesinger, Wiskirchen, & Duda, 2002). These stents are typically 3 I6L stainless
steel or cobalt chromium stent coated with the anti-tbrombogenic medication. The
medication is re leased of time to offset the biologica l agents responsible for in-stent
restenosis.
Contemporary sten ts are beginning to be manufactured from more exotic
materials that have promising biocompatibil ity and structura l integrity. One such
exotic material is Nitino l, a nickel and titani um al loy. Nitinol ex hibits superelastic
and shape memory characteristics. The superelastic and shape memory
characteristics are enabled through thenno-mechanical re ponse to stresses. These
characteristics allow

itinol to recover its ori ginal shape through a process of

mechan ica l unloading (Petrini, Mi gliavacca, Dubi ni, & Auricchio, 2003).

itinol 's

shape memory properties exist because the metal transfonns between an austenitic

18

composition and a martensitic composition under mechanical loading and exhibits the
stress/strain relationship shown in the figure below.

CT~,-,...----._.--~
Strain

Figure 4. Stress/strain relationship for Nitinol (Gopal, Kim, Swift, & Choules, 2008).
The stress/strain plot in Figure 4 illustrates the three major components of the
Nitinol stress response. The initial phase of the Nitinol stress response is an
austenitic loading. Nitinol then transitions to its martensitic composition at strains of
0.8% (Gopal, Kim, Swift, & Choules, 2008). The stress/strain plot also consists of a
superelastic area in which the Nitinol exists as both austenite and martensite. This
mixture of austenite grain structures and martensite grain structures exists at strains of
0.8% to 6% (Gopal, Kim, Swift, & Choules, 2008). Strains are fully recoverable in
the superelastic region because the ratio of austenite to martensite changes to
compensate for the varying stresses. An elastic-plastic region exists beyond strains of
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8% (Gopal, Kim, Swift, & Choules, 2008). This region marks the transition to a full
martensitic grain structure and plastic deformation.
Stents are also manufactured using biodegradable polymers. Biodegradable
polymer stents are absorbed into the body over a period of time. These biodegradable
stents have shown to induce minimal thrombosis, moderate neointimal remodeling,
and low rates of inflammation (Masia, 2008). Contemporary biodegradable stents are
being manufactured from poly-L-lactic acid (PLLA). Studies in rabbit arteries
showed that a PLLA stent had no inflammation response during the first six months
(Masia, 2008). The stent was completely degraded and absorbed with 24 months.
Biodegradable polymer stents have desirable physiological characteristics but do not
possess desirable mechanical properties (like mechanical strength for example) when
compared to metallic stents. Therefore, polymer stent must be designed with thicker
struts. The thicker struts allow the stent to overcome the compressive radial forces
imposed by the artery and the radial forces imposed by systolic and diastolic pulse
pressures.
PLLA is the most common biodegradable polymer stent material and exhibits
a viscoelastic nature. This viscoelastic state of PLLA introduces internal forces that
are created due to a distortion of the polymer chains in response to the external load
whenever an external load is applied. The viscoelastic response in PLLA exhibits a
stress relaxation, creep, and hysteresis. The stress response of PLLA can be shown
by the following equation (Masia, 2008).
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(5)
Where:
A is the principle stretch
p is the density

R is the universal gas constant
Tis the absolute temperature

Mw is the polymer molecular weight
The stress response of PLLA can be further represented through the use of
hyperelastic constitutive modeling. A polynomial strain density function can be used
to model the hyperelastic response of PLLA.

(6)
Where:

u1'1 is the material strain density function
Cy is a material constant

Ii is the first Cauchy strain invariant
Ii is the second Cauchy strain invariant
D I is the material compressibility factor

J,1 is material elastic volume strain
The stent' s material determines the stent classification. Stents can be
classified as either balloon expanding or self-expanding. Traditional metallic stents
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and polymer stents are balloon expandable stents. These stents use a balloon
mounted catheter to expand the crimped stent within the artery. The balloon expands
and applies a constant pressure against the crimped stent. Self-expanding stents are
manufactured from shape memory alloys such as Nitinol. These stents are able to
expand to their pre-crimped diameter by releasing the stored strain energy. Selfexpanding stents are crimped to the catheter. A removable sheath is placed over the
stent and the removed once the stent is located at the offending lesion. The stent
recovers its pre-crimped diameter once the sheath is removed.

Finite Element Analysis
Finite element analysis (FEA) is a branch of the finite element method (FEM)
that enables engineers to solve complex problems. FEA is based upon the theory that
a solid structure is a continuous element or a continuum (Budynas & Nisbett, 2006).
FEA separates this continuous structure into discrete elements. A complex solid
structure can contain thousands of discrete elements to form what is known as a
mesh. Each element of the mesh is connected by exterior nodes (Hutton, 2004).
Boundary conditions are applied to these nodes to create a partial differential
equation. Each node contains six degrees of freedom to which boundary conditions
can be applied. The six degrees of freedom include translation in X, Y, and Z axes
and rotation X, Y, and Z axes. Boundary conditions can include limitations on the
analysis such as limiting nodal displacement and/or rotation. The discrete elements
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are also given the mechanical properties of the structure's defining material. The
properties can include elastic and plastic properties.
The basic finite element can be thought of as a spring that can be defined by the
following equation (Budynas & Nisbett, 2006).
(7)
Where:

k is the spring rate
A is the element cross-sectional area
Eis the material's Young's modulus

l is the element length
This spring element consists of nodes positioned at each end for a total of two nodes.
These nodes can be designated as node one and two. The forces in the nodes can be
represented by displacement equations (Budynas & Nisbett, 2006).
(8)
(9)
These equations can be combined into a matrix form.

(10)

These problems become inherently complex as the number of nodes and
elements in the mesh increase. The complexity of such a problem would be difficult
to solve manually. Finite element analysis software helps aid in solving complex
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problems. Finite element software is adept at solving problems that include nonlinear
material definitions and large displacements. Therefore, FEA software is capable of
calculating the radial displacements of stent subjected to the pulsating pressures of the
heartbeat.
FEA software checks complex problems for convergence. The FEA solver
routine checks for boundary condition convergence in order to find the solution to
stresses and strains present within the problem. Convergence can be checked in two
ways. The first method involves increasing the number of degrees of freedom to
infinity. This increase is performed by keeping the element size constant. The
second method involves decreasing the element size to zero (Tong & Rossettos,
2008).

FEA involves three processes that work to develop the engineering problem.
These processes are preprocessing, processing, and post processing. The first process
is preprocessing. Preprocessing involves creating the geometric models of the parts
to be analyzed. Many FEA software packages allow for the geometry to be imported
from computer aided design software. Preprocessing also involves defining material
properties for the parts. Meshes of the finite elements are also created during the
preprocessing phase. Appropriate forces, boundary conditions, contacts, and part
interactions are also defined.
The processing phase of FEA involves submitting the preprocessed analysis to
the computer's processor. The partial differential equations are checked for
convergence in order to find a solution to the problem.
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Post processing occurs after the software has found the solutions. Post
processing is necessary in order to view the results from the processor. This phase
involves viewing the parts deformed shape as well as relevant stresses and strains.

Background Study
Significant research has gone into the study of arterial wall mechanics and
intravascular stent response. Early and Kelly studied the impact of arterial geometry
and material properties on stents. The significance of this study was to define the
mechanical properties of the intimal, medial, and adventitial layers of the artery wall
and found that these layers are isotropic and incompressible. This nature can be
defined by a third order Mooney-Rivlin strain energy function. The strain density
function developed by Early and Kelly is given below.
2

3

W = CIO ( II -3) + COi ( lz -3)+ c,o (II -3) + ell ( JI -3)( 1, -3) + c,o (II -3) (11)
Where:
Wis the strain energy function

C is a material constant
11 is the first Cauchy strain invariant

Ii is the second strain invariant
Further studies have also been done to investigate the mechanical properties
of atherosclerotic plaques. Maher et al. studied the mechanical response of
atherosclerotic plaques from fresh carotid arteries (Maher, Creane, Sultan, Hynes, &
Lally, 2009). This study was performed on a total of fourteen atherosclerotic plaques
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which consisted of calcified, lipid, and fibrous atherosclerotic plaques. The plaques
were found to be isotropic, incompressible hyperelastic materials. The data from the
study was fit to a second order polynomial hyperelastic strain energy function.
W

= C10 (11 -3)+ C01 (11 -3)+C20 (11 -3)2 +C11 (11 -3)(12 -3)+ C02 (12 -3)2

(12)

Where:

Wis the strain energy function
C is a material constant
11 is the first strain invariant

Ii is the second strain invariant
Several studies have also been done on stent mechanics. Studies have proven
that finite element analysis is a viable method for designing stents as well as testing
stent mechanics. Zahedmanesh and Lally studied the impact of strut thickness on instent restenosis using finite element analysis (Zahedmanesh & Lally, 2009). They
created models of a stenosed artery. They also created models of the ACS RX
MultiLink stent and an ACS Multilink RX Duet stent that have dissimilar strut
thicknesses. The strut thicknesses were 50 nanometers and 140 nanometers,
respectively. The stents were deployed within the stenosed artery model. The study
showed that stents with thinner struts led to lower stresses within the arterial wall.
De Beule et al. investigated the phenomena of stent dogboning using FEA (De
Beule, Van Impe, Verhegghe, Seger, & Verdonck, 2006). The authors modeled a
slotted tube stent using 316LN stainless steel in its unexpanded state. This was
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necessary in order to model the stent as a balloon expandable stent. A uniformly
distributed pressure was applied to the inside surface of the stent in order to simulate
the balloon expansion. Dogboning was defined by the following equation.

DB =

Rload

Rload

distal -

central

Rload

(13)

distal

Where:
DB is dogboning

R~~ffai is the radius of the stent at the distal end under load
R~~~fral is the radius of the stent at the center under load
A distal radius that was significantly larger than the radius of the stent' s center
indicated dogboning. Dogboning occurred when the ends of the stents inflated to a
larger diameter than the center. This caused the end of the stent to contact the artery
first, leading to an uneven stress on the artery. De Beule et al. also varied the stent
geometry to study the occurrence of dogboning. The study found that asymmetric
stent geometry reduced dogboning.
Migliavacca et al. also studied the deployment of a stent in a stenosed artery
(Migliavacca, Petrini, Auricchio, & Dubini, 2003). A geometric model of an
unexpanded stent and a diseased artery were created. Migliavacca et al. used
Abaqus® software to study the large displacements and strains associated with stent
expansion. The artery was loaded with a pulse pressure of 110 mmHg. The inside
surface of the stent was subjected to a pressure of 2 MPa. The study showed that
arterial stresses are concentrated at contact points with the stent. Lesser amounts of
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stresses were located at non-contact points. The study also showed that stiffer
atherosclerotic plaques require a larger stent inflation pressure to reach the same
lumen gain as a softer plaque.
Li and Gu used FEA and parametric design theory to optimize the shape of a
periodic curved wire stent. The optimization was done to reduce the stent's elastic
recoil and foreshortening after expansion within the artery. This optimization study
allowed the dimensions of the stent strut to vary in order to achieve the goals of
reducing elastic recoil and foreshortening.
Cervera studied the impact ofstenting of the behavior of the arterial wall (Cervera,
2006). He modeled the artery as an idealized, hollow cylinder that was stretched by
59% of its length in order to simulate axial tethering. Matlab was used to create
parametric stent geometries. The stents were parameterized in order to include the
best features from other stent designs and was used to optimize stent strut spacing,
axial amplitude, and the stent' s curvature radius. The FEA study involved inflating
the artery in order to provide luminal dilation. Each stent created through the
parametric study were tested in the artery model and analyzed for critical stresses. It
was found that stent geometry influences the magnitude of the stresses present in the
arterial wall after stenting. The influence of pulse pressure and compression from the
artery also led to an increase in stent hoop stresses (Li & Gu, 2005).
Timmins et al. also studied stent artery mechanics. The authors worked to
optimize stent performance. The goal was to optimize the stent geometry in order to
minimize stent hoop stresses associated with diastolic pressure. A variety of stent
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designs were created and studied. The study showed that in order to reduce the
circumferential stent stress, strut spacing need to be increased. It was also determined
that the stent design not only affects the structure integrity of the stent but also the
stress concentration in the artery. This finding indicated that there must be a
compromise between stent structural integrity and arterial wall stresses (Ti=ins, et
al., 2007).
Even though quite a bit of research has used FEA to study the mechanics of
arteries and stents, relatively little has been done to study the effect of fatigue on a
stent. The majority of these studies were performed on peripheral arteries that are
subjected to bending and pulmonary arteries that are subjected to respiration. Hsiao
et al. studied the impact of kidney motion and respiration on a cobalt-chromium stent
(Hsiao, Nikanorov, Prabhu, & Razavi, 2009). The cobalt-chromium stent" was studied
in order to see if the stent could withstand 4 X I 08 cycles. These cycles represented
systolic/diastolic cycles as well as respiratory cycles. The stent model was crimped
using FEA and expanded to simulate clinical practices. The stent was then subjected
to the systolic/diastolic and respiratory cycles. A Goodman failure criterion was used
to analyze the fatigue of the stent. Goodman failure criteria can be defined as shown
in the equation below.

(14)

Where:

cr. is stress amplitude applied to the stent
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cre is the material endurance limit
O"m

is the mean stress

cru is the material ultimate tensile strength
The fatigue safety factors were determined and plotted to determine the ratio
of stress amplitude to the material endurance limit. The study showed that there is no
significant risk of fatigue failure in kidney deployed cobalt-chromium stents.
Marrey et al. also studied the fatigue of cobalt-chromium stents. The stent
was crimped onto a balloon and then d_eployed into the artery. The artery was
modeled as a hyperelastic tube. After the stent was expanded, pressures representing
systolic and diastolic pressures were applied to the inside of the artery. The
maximum principle stress was analyzed in order to determine the fatigue life. The
fatigue factors of safety were calculated in accordance with modified Goodman
failure criteria (Marrey, Burgermeister, Grishaber, & Ritchie, 2006).
Gopal et al. studied the fatigue life ofNitinol. A geometric model of a Nitinol
stent was created in order to be studied using FEA. A rigid cylinder was used to
expand the stent from its unexpanded state. Axial, bending, and torsional loads were
applied to the stent. The mean strain and alternating strain were plotted for each load
(Gopal, Kim, Swift, & Choules, 2008).
Perry et al. studied stent fatigue using FEA to analyze the cyclic in-vivo
pressures and their impact on the stent. It was found that the stent diameter changes
in-vivo due to the cyclic pulse pressures. These changes in stent diameter induce

alternating stresses within the artery. The stent was subjected to one complete cyclic
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loading. The mean and alternating stress were computed for each finite element
integration point. These stresses were plotted and compared to a modified Goodman
diagram. This study also indicated FDA recommendations for stent fatigue testing.
Stents must have a minimum fatigue life of 10 years at a heart rate of 72.3 beats per
minute. This is equivalent to 380,008,800 pulse cycles (Perry, Oktay, & Muskivitch,
2002).
Li et al. examined the viability of FEA as a tool in studying stent fatigue. A
balloon expandable stent was modeled. Cobalt-chromium was chosen as the stent
material. Tubular cobalt-chromium specimens were tested in order to develop an
accurate material model. The stent was crimped to its in-vivo delivery diameter. A
rigid cylinder was used to expand the stent to its nominal diameter. A radial
compressive force was applied to the outside of the stent in order to simulate the
compressive forces of the artery wall and acyclic pressure of0.0133 MPa was applied
to the inside of the stent. The mean and alternating stresses of the finite elements
were plotted in a modified Goodman plot. A physical stent was also analyzed using
fatigue testing equipment. Latex was used to represent the artery. A saline solution
was used to simulate physiological conditions. The results of this physical test were
compared to the FEA results indicating that FEA is capable of determining stent
fatigue (Li, Lu, Xie, & Li, 2010).
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Chapter Three
Problem Statement
In-vivo stent fatigue can lead to stent failure. This can failure can lead to instent restenosis, thus leading to a loss of patency within the artery. Finite element
analysis techniques combine with appropriate failure criteria can be used to
accurately predict stent failure. This research aims to use finite element analysis and
modified Goodman failure criteria to analyze the impact of stent design and stent
material on fatigue life.

Methodology:
Three dimensional models of stents from Nitinol Devices and Components®
(Laserage®) and Cordis® will be created using SolidWorks® design software. A
custom design will also be created and optimized using SolidWorks®. SolidWorks®
allows user to perform an optimization design study in which variables, constraints,
and goals are defined. The variables are the dimensions that are allowed to change
within the model. The variables will include stent strut thickness, strut width, and
strut length. The constraints for optimization will include the overall length and
diameter. It will be necessary for the stent diameter and length to be constrained in
order to design a stent that will be compared to commercial stent sizes. The
optimization will have several objectives. SolidWorks® Simulation will be used to
perform a static stress test on the generated stent designs. The goal will be to
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minimize the stress in the stent. The stent strut thickness will also be minimized in
order to reduce the chance of in-stent restenosis.
A three dimensional model of an artery and its stenotic plaque will also be
created. The artery and plaque will be modeled to represent the in-vivo physiological
state. This will involve using the FORTRAN programming language to develop an
Abaqus® subroutine that will model the artery's hyperelastic behavior. The specific
subroutine will be an Abaqus® Standard uhyper routine. The uhyper routine allows
for Abaqus® to use complex compressible and incompressible hyperelastic material
models. This uhyper routine requires that partial derivatives of the hyperelastic strain
energy function be defines with respect to the strain invariants (Simulia). The
subroutine will be tested using two dimensional arterial cross sections.
The artery will be modeled in its in-vitro phase. Once an artery is removed
from the body, it elastically recoils. This recoil indicates that a stent removed from
the body is in a no load stated and an artery that is in-vivo is in a loaded state (Fung,
2002). The no load model of the stent will be axially stretched in order to simulated
the artery's in-vivo conditions.
The stent models will be crimped using the Abaqus® adjustable rigid torus
extension (Simulia Central, 2011). The adjustable rigid torus extension is an
Abaqus® addin specifically designed to model the crimping and expansion of stents.
The extension uses a rigid cylinder with a changing radius. The stents will be crimped
to allow for a low profile and thus allow the stent to be placed in the stenosed artery
model.
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A sinusoidal pressure curve will be used to represent the periodic nature of the
systolic and diastolic blood pressures. The pressure will be applied to the inside
surface of the stent. The alternating stresses will be calculated to determine the stent
fatigue life.
An analysis of variance (AN OVA) will be performed to determine if stent
design or material is the determining factor in stent fatigue life. Each stent design
will be test using 316L stainless steel, Nitinol, and PLLA as the material. Minitab
will be used to develop a factorial experimental design to analyze the levels and
factors. This experimental design will consist of two factors. The factors will be
stent design and stent material, respectively. The stent design factor will have levels
of the Nitinol Devices and Components® stent design, the Cordis® stent design, and
the custom design. The material factor will have levels of 3 l 6L stainless steel,
Nitinol, and PLLA. The levels and factors will be measured for its response to
fatigue safety factor and fatigue life.
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Chapter Four
Chapter four presents the analysis and finding of this thesis. The development
and testing of an artery and atherosclerosis are presented using hyperelastic
mechanics and finite element analysis. Commercial stent geometries are also
presented. The steps necessary to parametrically design a stent are also presented in
chapter four. The stent materials properties are defined as well. The stent crimping,
expansion, and fatigue mechanics are also presented. A factorial design and its
resulting analysis are described at the end of chapter four.

Artery and Atherosclerosis Mechanics and Modeling
Early and Kelly found that the arterial layers (intima, media, and adventitia)
can be modeled as an isotropic material (Early & Kelly, 2010). Furthermore, Early
and Kelly found that each respective layer exhibits an incompressible hyperelastic
nature. Maher et al. also found that fibrous, calcified, and lipid plaques can be
modeled using an incompressible hyperelastic strain energy function (Maher, Creane,
Sultan, Hynes, & Lally, 2009). The general form of the polynomial hyperelastic
strain energy function is shown below (Simulia).
(15)
Where:

if•I is the strain energy function
Cif is a material constant
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11 is the first Cauchy stress invariant

Ii is the second Cauchy stress invariant
DI is the material compressibility factor

J,1 is the elastic volume strain or third Cauchy invariant

The Cauchy invariants are defined using principle material stretches.
(16)
r

(17)
Where:
')..,, is the material principle stretch
An incompressible hyperelastic material has a D I value that is equal to zero.
This corresponds to a Poisson's ratio of0.5. The Poisson's ratio can be defined as
shown in the following equation.

V

Where:
vis the Poisson's ratio

K 0 is the bulk modulus
µ 0 is the shear modulus

(18)
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The incompressibility is further defined using the third Cauchy invariant, JeiThe third invariant is equal to one in an incompressible hyperelastic solid. The
deformation gradient thus becomes:
(19)

The infinite deformation gradient leads to a solid that does not change volume
when undergoing strain.
The incompressibility of a hyperelastic solid can also be described
using the principle stretches. Lai et al. showed that an incompressible solid has an
equilibrium state shown below (Lai, Rubin, & Krempl, 2010).
(20)
(21)

x3 = .4.,x3

(22)

Where:
x is the longitudinal direction

).. is the principle stretch in the longitudinal direction

An incompressible solid possesses an equilibrium state between the first and
second principle stretches.

(23)
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This equilibrium state leads to an isochoric response in the material (Lai,
Rubin, & Krempl, 2010). The isochoric response indicates no change in the
material's volume during stretch.
Early and Kelly defined the artery layers using a third order MooneyRivlin hyperelastic function (Early & Kelly, 2010). The Mooney-Rivlin strain energy
function is a special case of the polynomial strain energy function. The MooneyRivlin strain energy function is defined below.

(24)

Table 1 shows the material constant values in megapascals (MPa).
Table 1
Arte1y Layer Hyperelastic Constants (MPa) (Early & Kelly, 2010)

Cio
Co,
Cw
lntima
0.08423 0.00505
1.5
0.76506 0.04238
Media
0.00355 0.00066 0.02154 0.01868 0.01977
Adventitia 0.00714 0.00063 0.00803 0.09579 0.09931

Maher et al. defined the atherosclerotic plaque using a second order
polynomial strain energy function (Maher, Creane, Sultan, Hynes, & Lally, 2009).

Table 2 contains the material constants for three varieties of atherosclerotic
plaque in MPa.
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Table 2
Atherosc/erotic Plaque Hyperelastic Constants (MPa) (Maher, Creane,

Sultan, Hynes, & Lally, 2009)
Cw
Cw
Fibrous
0.00753 0.00999 0.02063
Lipid
0.00116 0.01168 0.00858
Calcified 0.001144 0.01357 0.06238

Cn
0.00039 0.00078
0.0006 0.00022
0.02626 0.00761

A FORTRAN subroutine had to be written in order to implement the
aforementioned strain energy functions in Abaqus®. In particular, a uhyper routine
was written to model the hyperelastic nature of the artery and plaque. The Abaqus®
manuals recommend that incompressible materials be modeled as nearly
incompressible (Simulia). A bulk modulus to shear modulus ratio of 10,000 was used
to model a nearly compressible behavior. A bulk to shear modulus ratio of 10,000
leads to a Poisson ratio of0.4995. A fully incompressible hyperelastic solid has a
Poisson ratio of 0.5. Therefore, a Poisson ratio of 0.49995 has some compressibility.

Ko ::::: 10, 000

µo

(26)

3Ko -2
V

':(

:::::

0.49995

6 - +2
0

A
A bulk modulus to shear modulus ratio of I 0,000 led to an approximate
Poisson's ratio of0.49995. Therefore, the materia!compressibility factor (D 1)
became non zero. The compressibility factor for each arterial layer and

(27)
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atherosclerotic plaque were recalculated to obtain a nearly incompressible
hyperelastic response. The compressibility factor is a function of the material's
Poisson's ratio and the linear components of the strain energy function (Cw and C 01 ).
(28)
Table 3 shows the D1 values for each artery layer and plaque component.
Table 3

Hyperelastic Compressibility Factors (MPa)
Component

D1 Value

lntima

0.000008928

Media

0.000000421

Adventitia

0.00000077

Calcified

0.0000014714

Lipid

0.000001284

Fibrous

0.000001752

The uhyper subroutine also required that partial derivatives with respect to the
strain invariants (11, Ii, and J,1) be calculated. The partial derivatives defined the
. response o f the stram
. energy fu nct10n.
.
Th ese partia
. 1 d envatlves
. .
e1astlc
are -8U , -8U ,
8 fi

8 /2

are the partial derivatives for the artery's Mooney-Rivlin strain energy function. The
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uhyper subroutine ignores any partial derivative that is equal to zero. Therefore,
these partial derivatives are ignored in the following calculations.
(29)

(30)

oU

2J-2

-=--

(31)

(32)

(33)

(34)

The partial derivatives for the plaque components were calculated. The
plaque components were modeled using a second order polynomial hyperelastic strain
energy function.
(35)

(36)

oU

2J-2

oJ

D1

-=

(37)

41

(38)
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(39)

(40)

(41)

2 2

These calculations were compiled into a FORTRAN subroutine. The subroutine was
tested using a combination of two dimensional and three dimensional artery models. A two
dimensional quarter model was first created in order to test the subroutine and boundary
condition assumptions. The artery was modeled in relation to the left anterior descending
artery (LAD). Suter et al. prescribed artery layer thickness to lumen diameter ratios (Suter, et
al., 2009). The LAD was modeled using the mean lumen diameter of 4.38 mm. The artery
was also modeled using the mean outer diameter of 5.45 mm. Holzapfel et al. investigated
the ratio of artery layer thickness to artery wall thickness (Holzapfel, Sommer, Gasser, &
Regitnig, Determination of Layer-Specific Mechanical Properties of Human Coronary
Arteries with Nonatherosclerotic Intimal Thickening and Related Constitutive Modeling,
2005). It was found that ratios for the adventitia, media, and intima were 0.4, 0.36, and 0.27
respectively. These ratios were used to model the artery layer thicknesses.
A two dimensional quarter model of the diseased artery was created by adding a
calcified intima, lipid core, and fibrous cap. Figure 5 illustrates the quarter model.
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T

t..
Figure 5. Artery quarter model (green is advcntitia; brown is media: blue is intima:
white is ca lcified; grey is lipid core: red i fibrous cap).
The model was meshed using a globa l seed factor of 0.05 . The mesh u ed
CPS4 shell elements. A boundary condition of U2 equals zero was applied to the
nodes along the x axis. Boundary cond itions of U I equals zero were app lied to nodes
along the y axis. A boundary condition on degree of freedom U I is synonymous with
the X ax is whi le U2 is synonymous with the Y axis. A pressu re of 0.013 MPa was
applied to the lumen surface of the model. This pressure conesponded to the mean
blood pressure through the artery. Figure 6 shows the mesh and bounda1y conditions.
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L.
Figure 6. Quarter model mesh and boundary condi tions.
The stresses induced by the mean blood pressure i shown is Figure 7.

Figure 7. Quarter mode l von Mises stresses (M Pa).
The quarter model wa al o ex tended to a two dimensional fu ll model. The
same meshing and boundary condi tions were applied to the fu ll model. Figures 8 and
9 shows the boundary condi tions and stresses.
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L.
Figure 8. Full model mesh.

f igure 9. Full model von Mi ses stres es (MPa).
Jt is well known that an in-1·ivo artery is in a loaded stated (Fung, 2002). A

healthy artery can be stretched up to 50% of its original in-vitro length.

This in-vivo

tethering allows the artery to evenly distribute the blood pressure along the
endothelium. Fox et al. showed that the LAD can have a length of 32 mm (Fox,
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Davies, & Webb-Peploe, 1973). Therefore, an in-,·ivo LAD is ·tretched by 50%;
add ing a 16 mm to the tota l length.
A three dimensional mode l of the LAD was created using the in vitro length
of 32 mm. Displacemen t boundary cond itions of 8 mm were applied in the ax ial
di rection. These boundary cond ition were applied on both the proximal and distal
faces of the artery. Symmetry boundary conditions were also app lied to the nodes
along the x axis and y axis. Hybrid mesh elements were used to mesh the artery.
Hybrid elements enforce a Poisson 's ratio of 0.5 in the tiffness matri x. This helped
to model the incompressible nature of the arterial wa ll layers. C3D8H eight node
solid brick elements were used to capture the stresses induced by arterial tethering.
Figure IO shows the three dimensional model with the prescribed boundary
conditions.

Figure I0. Arteria l tethering mesh and boundary cond iti ons.
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Von Mises stres es and noda l displacement was monitor to determine the
residual state of the in- vivo artery. Figure 11 shows the Von Mises stresses and fi gure
12 nodal di splacements.

. ---- _ . . . ._ --•u•- ----.
..1..
Figure 11 . In-vivo arteria l layer res idual stresses (MPa).

Figure 12. Tethered artety displacement.
Stress was contained within the load bearing adventitia and media layers. The
thin intima l layer also had stress concentration. The nodes on the front and back
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faces of the artery were displaced using a di placement boundary condition in the X
direction. The nodes on the front face were displaced 8 mm and the nodes on the
back face were displaced negative 8 mm.
A mean pressure of 0.013 MPa wa applied to the tethered artery model. The
boundary and mesh conditions from the tethering mode l were obtained in order to
model the in-,•ivo state. Figure 13 illustrates the blood pressure induced stresses .

.
tA.

5-.::~-=-=-"'Figure 13. Arterial tre se due to blood pressure (MPa).

48

S M1~i:s.
~vg 1~%
+7.997e+OV

+ 7 348e... oo
+6 698•-0C

04'::le+Ol
400e+OO
750e+OO
lO l e-00
.+ 3 452e400
+6
+5
+4
+4

+2 eo2e.,.oo
+2 153h·00

+I 504e-OO
+8 544e-0I
+2 0Sle·01

'""·

...

' - -..

:

'""-•·-·

►-... l.,_,,
,,.._._"" • t-tio - • -

ttot
• , _ •I flfOt•M

Figure 14. Stresses along the a11eri al lumen due to blood pressure.
The blood pressure induced a localized stres within the intimal layer. A it is
known, the intima serves to iso late the bl ood fro m the media and adventitia. The
artery model showed the axial load bearing nature of the adventitia and media. It also
indicated the blood pres ure regulating nature of the intima.

Stent Modeling
Solid Work

Jl

was u ed to create three dimensional models of the stent

geometries. The stents were selected lo fit a large coronary artery having a diameter
of 4 mm. The Handbook o_fCoronary Stel1ls was surveyed in order lo find
appropriately dimen ioned tent (Ren ing, 2007). A slotted tube stent imilar lo the
original Palmaz stent was selected. This stent geometry wi ll be further refeITed to as
stent A in thi paper. Stent A was modeled to have an expanded diameter of 4.1 mm
and a wall thicknes of 0.0635 mm.
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A generic test stent from Laserage/Nitinol Devices and components was also
selected. This stent will be further referred to as stent B. Stent B was modeled to an
expanded diameter of 4.07 mm and a wall thickness of 0.3556 mm. A physical
specimen of stent B was available. A photograph of stent B is shown below.

Figure 15. Scanning electron microscope photograph ofstent b.
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Figure 16. Scanning electron microscope photograph of stent b strut design.
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Figure 17. Scanning electron microscope photograph of stent b strut and bridge
connection.
Two rows and bridges of each stent were modeled for symmetry. The use of
symmetry allowed for a better mesh quality and reduction of equations in later steps.
Figure 18 shows the final geometries of stent A and stent B.
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(a)

(b)

Figure 18. (a) stent a geometry, (b) stent b geometry.
A SolidWorks® design study was performed to design a stent strut geometry
that is capable of minimizing the stresses present within the stent. Bonsignore
showed that a stent strut and bridge configuration can be separated into a series of
beams. The loads on these beams can then be solved to determine the forces and
strains in the stent (Bonsignore, 2010). These forces and strains can be solved using
simple mechanics.
3w

S=-o
L2

(42)

(43)

Where:
s is the strain
w is the strut width
L is the strut length
F is the force

Eis the material's modulus of elasticity
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I is the moment of inertia of the strut cross section
6 is the beam deflection

The Handbook of Corona,y Stents shows that the majority of contemporary
stents are open cell designs that feature periodic strut patterns (Rensing, 2007). Open
cell stents have a lower number of strut connecting bridges as opposed to a closed cell
design. Not all adjacent struts are connected to one another in an open cell design. A
stent with an open design has more flexibility while providing sufficient radial
strength.
A combination of SolidWorks® design studies and SolidWorks® Simulation
finite element analysis was used to determine the stresses within the stent. The strut
was sketched to a rough approximation of the desired shape. Dimensional variables
and constraints were added to the sketch in order to create a parametric study.
The sketch was given a starting thickness of 0.125 mm. An initial FEA study
was performed to determine the adequacy of the starting strut design. The stent was
meshed using the fine mesh property in SolidWorks® Simulation. A uniformly
distributed pressure of0.016 mm (equivalent to systolic pressure) was applied to the
top surface of the strut. Fixed boundary conditions were also applied to one end of
the strut as prescribed by Bonsignore (Bonsignore, 2010). Figure 19 shows the mesh
along with loading and boundary conditions. The green arrows represent the
constrained degrees of freedom due to boundary conditions. The orange arrows
represent the location and direction of the uniformly distributed pressure.
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Figure 19. Stent strut loading and boundary cond itions.
The strut was found to have a maximum stress of 43. 7 MPa as shown
in Figure 20.
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Figure 20. lnitial stent strut stresses.
The dimensions were then all owed to change in order to minimize the
maximum stresses present within the strut. The strut half width was al lowed to vary
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between 0.5 mm and 1.25 mm. Any dimension within this range takes stent crimping
spacing into consideration. The strut length varied from 2.25 mm to 3 .25 mm. These
bounds were placed on the strut length in order to keep the strut dimensions at a
reasonable size. Too large a strut length could potentially influence the strut spacing.
The fillet radius was allowed to vary between 0.2 mm and 0.5 mm in order to reduce
stress concentration at the tip of the strut. The strut thickness had bounds of0.025
mm to 0.25 mm. These bounds were placed on the strut due to considerations of
restenosis. Thicker stent struts typically have higher restenosis rates as compared to
thinner struts. The strut thickness also influences the section modulus of the strut. A
larger section modulus helps to reduce the stresses present. The strut wall thickness
was given the same bounds as the wall thickness in order to influence the section
modulus.
The strut design study had 41 iterations. The parametrically designed strut
reduced the maximum stresses to 7 .5 MPa. Figure 21 shows the stress distribution in
the parametrically designed stent.
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Figure 2 1. Stresses within the parametrically designed strut.
The connecting bridge were also parametrically designed. The bridge was
designed in the same manner as the strut. An initial sketch of the bridge was created
with bounds on the length and width. The constraints on the length and width allow
the bridge to connect with tbe adjacent struts. The wall thickness was also
constrained to be equal to the wall thickness of the strut. The constraint on the wall
thickness allows for a uniform transition between the strut and the bridge.
The bridge leg length was given bounds of 0.0125 mm to 1.125 mm. These
bounds provided a constraint that prevented the bridge from colliding with the
adjoining strut. The bridge half width controlled half of the bridge thickness. This
dimension was given bounds of 0.075 mm to 0. 125 mm. An equation that sets the
fu ll bridge thickness to two times this dimension was created to control the full bridge
thickness.
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The bridge design study contained 9 combinations of variable . The bridge
wa loaded and meshed similar to the strut. The fine mesh option was u ed to create
a high quality mesh. The uniformly distributed pressure of0.0 16 MPa was applied to
the bridge. Both ends of the bridge were fixed in order to mimic the connections to
the stent strnts. Figure 22 shows the bridge me h and loading conditions. The green
arrows indicate constrained boundary conditions and the red arrows indicate the
uniform ly distributed pressure.

Figure 22. Bridge loading and boundary conditions.
The bridge had a maximum stress of 0.856 MPa as shown in Figure 23. The
parametric design study showed that thi s bridge configuration is capable of
minimizing the maximum bridge stresses.
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___ ,._.,"""""

Figure 23. Bridge stresses (M Pa).
The strut design and the bridge design were combined to create the final stent
geometry. In order to create a stent in Solid Work

Jl,

the stent must first be modeled

using two dimensional modeling techniques to model the stent in its unwrapped
configuration. A stent in its unwrapped confi guration has a width equal to the
wrapped diameter. The circumference of the stent can be defined using the
conventional circle circumference equation.

C = Jrd

(44)

Where:
C i the tent circ umference or the width of the unwrapped stent

dis the wrapped stent diameter
The struts were aligned in a pattern that gave the stent a circumference similar
to those of stent A and stent B. II was only necessary to model two rows of struts due
to symmetry.
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The unwrapped configuration was then wrapped inside a hollow three
dimensional tube. The inside diameter of the tube had a diameter equal to the
unwrapped circumference divide by pi. This diameter is also equal to the wrapped
stent diameter.
(45)
Where:
dis the hollow tube inside diameter and the stent diameter
C is the stent circumference

The wrapped stent was given a wall thickness equal to the thickness found in
the parametric design study (0.25 mm). The hollow tube was then cut from the stent
to reveal the wrapped stent geometry. This final stent will be referred to as Stent C in
this paper.

Figure 24. Final stent c in the wrapped configuration.
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Stent Materials
Nitinol, 316L stainless steel, and poly-L-lactid acid (PLLA) were chosen for
stent materials. These three materials are representative of commonly used
biocompatible stent materials.
Nitinol is an exotic shape memory alloy. It consists of a mixture of 50%
nickel and 50% titanium. This material has an unusual unloading pattern due to the
shape memory effect. Figure 4 in Chapter II shows the typical stress and strain
unloading path for Nitinol. Nitinol is able to recover large strains due to a mixture of
austenitic and martensitic grain structures. The ratio of the austenite and martensite
grains change when undergoing stress. The built-in Nitinol subroutine was used to
model the shape memory effect. The subroutine required the material properties for
the austenite and martensite grain structures to be entered. The values are shown in
Table 4 (Santillo, 2008).
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Table 4
Nitinol Material Values
Material Properties

Property Description

Value

EA

Austenite Elastic Modulus

35,877 MPa

VA

Austenite Poisson's Ratio

0.33

EM

Martensite Elastic Modulus

24,462 MPa

VM

Martensite Poisson's Ratio

0.33

i

Transformation Strain

0.0555

(!;)

(!;) Loading

6.7

uf

Start of Transformation Loading

489 MPa

uf;

End of Transformation Loading

572MPa

To

Temperature

22 °C

(!;) Unloading

6.7

uJ

Start of Transformation Unloading

230MPa

u5

End of Transformation Unloading

147 MPa

UcL

s

Start of Transformation Stress

0.0

EL

Volumetric Transformation Strain

0.0474

(!;)u

V

Austenitic 316L stainless steel was also chosen as a stent material. Medical
grade 3 l 6L stainless steel has the alloying components presented in Table 5 (The A to
Z of Materials, 1999).
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Table 5
316L Stainless Steel Alloying Elements and Their Percentages

C

I

% 0.03

Mn

Si

p

s

2.0

0.75

0.045

0.03

Cr

Mo

18.0 3.00

Ni

N

14.0

0.10

The Ramberg-Osgood material model was used to determine the
elastic/plastic response of the 316L stainless steel (Charalambides, 2011). This
model is also known as a deformation plasticity model.

(46)

Where:
s is the strain
cr is the stress
cr0 is the yield stress

a ~ is the yield offset
E is the elastic modulus
n is the strain hardening exponent

Yield strength of375 MPa and ultimate tensile strength of 474 MPa was used
for stent grade 3 l 6L stainless steel (Bargiggia, 2008). Table 6 shows a summary of
the material properties for 3 l 6L stainless steel.
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Table 6
3 I 6L Stainless Steel Material Properties
E

V

O"urs

n

O"o

aE

200,000 MPa 0.33 375 MPA 474 MPa 5 0.002

PLLA is a biodegradable polymer that has begun to be used in cardiovascular
stents. This material is known to completely biodegrade within 24 months of stent
insertion. PLLA can be modeled using a second order hyperelastic strain energy
function.

Where:
U is the incompressible strain energy function
C is a material property constant

11 and h are Cauchy strain invariants
The hyperelastic constants are shown in Table 7 (Masia, 2008).
Table 7
PLLA Hyperelastic Constants (MPa)

Co1

C20

Cn

-2799.14 2913.45 27,122.10 -515.45 -21,168.36
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Stent Crimping and Expansion
Stent crimping and expansion are necessary in order to add residuals stresses
to the stent materials. Crimping and expansion take advantage of material plasticity
to increase radial strength. Residual stresses from crimping and expansion are
present in the stent even in a no load condition. It is important to model to accurately
model these residual stresses in order to properly define the in-vivo conditions. The
Abaqus® adjustable rigid torus (ART) plugin was used to control both stent crimping
and stent expansion. The ART plugin uses cylindrical displacement boundary
conditions and contact controls to control both stent crimping and expansion. The
displacement boundary conditions cause the rigid cylinder radius to either increase
(balloon expansion) or decrease (crimping). Balloon expansion uses a position
displacement vector to increase the rigid cylinder's radius; while a crimping contact
uses a negative displacement vector to decrease the radius. The user specifies the
starting and ending cylinder radius as well as the contact type. Figure 25 shows the
graphical input for the ART plugin.
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Figure 25. Adjustable rigid torus contact definition window.
The user also specifies the stent contact surfaces. The contact surfaces define
the points on the stent in which the rigid cylinder contacts. Typ ica lly, the iru1er stent
surface is defin ed for balloon contact and the outer stent surface is defined for
crimping contact. Figure 29 g ives an example of a balloon rigid cylinder and a
crimping rigid cylinder.

,J.

(a)

(b)

F igure 26. (a) balloon contact and (b) crimping contact.
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Different crimping/expansion strategies were needed for 3 I6L sta inless steel
and Nitinol, respectively. The sten ts were meshed using 8 node C3D8R hexahedral
brick elements as prescribed in the literature (Rebelo, Fu, & Lawrenchuk, 2008).
Global seeds of 0.1 75 and 0.1755 were used to facilitate tbe replicates in the
statistical analys is. The 3 I 6L stainless stee l req uired that the ART plugin perform
both crimping and balloon expansion. A boundary condition that restrained linear
translations in the axial (X axis) direction was added to one nodal point on the stent.
This boundary condition eliminated a rigid body translation due to the crimping and
expansion forces. The stents were crimped to a radius of I. 75 mm. The stents were
first crimped to a radius of 1.75 mm. Figure 27 shows the three stems in their
crimped configuration.

(a)

(b)

(c)

Figure 27. Crimped configurations for (a) stent a, (b) stent b, and (c) stent c.
A balloon contact was then used to expand the stents from the crimped profile
to the expanded diameter. The same stent boundary conditions from the crimping
step were used during expansion. The rigid torus representing the expansion balloon
was displaced to a radius of 2. 15 mm. The cylinder was then displaced with a
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negative vector. The same balloon contact was used to control the stent surface. The
negative balloon vector is analogous to balloon retraction after stent expansion. This
was a crucial step in the stent expansion simulation because 3 l 6L stainless steel
stents elastically recoil after expansion. The elastic recoil causes the stent to
experience a small loss in expanded diameter and also a small decrease in residual
stresses after expansion.
Nitinol was allowed to self-expand due to its shape memory properties.
Nitinol stents have the unique ability to recover their original diameter after crimping.
Devices called sheaths are used to prevent the Nitinol stent from recovering its. shape
until arterial insertion. The sheath is removed from the stent after insertion, allowing
the Nitinol stent to self-expand within the artery. The ART plugin was used to
simulate both the crimping tool and the sheath. A node on the stent was constrained
in the axial direction in order to prevent unwanted rigid motions. The rigid cylinder
was negatively displaced using a crimp contact with the stent. The stent was crimped
to a radius of 1.75 mm. The motion of the crimping tool was reversed using positive
displacement vectors (the contact remained a crimping contact with the stent). The
positive displacement represented the removal of the sheath. This removal allowed
the Nitinol to recover the strain from the crimping step. Thusly, the stent returned to
its original diameter.
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Fatigue Loading and Study
Arterial blood pressure is periodic in nature. More specifically, it can be
modeled using a sinusoidal function. Rebelo et al. found that the blood pressure has a
mean value of 100 mmHg (0.013 MPa) (Rebelo, Fu, & Lawrenchuk, 2008). The
blood pressure has a systolic value of 120 mmHg (0.016 MPa) and a diastolic value
of 110 mmHg (0.010 MPa). Rebelo et al. also indicated that the blood pressure curve
has a periodic frequency of 1.2 Hz. A sinusoidal function was developed using the
data presented by Rebelo et al. The circular frequency of the function was calculated.
w

= 2trf

(48)

Where:
co is the circular frequency

/ is the frequency
Blood pressure has a circular frequency of7.53982 radians/second at a
frequency of 1.2 Hz. The sinusoidal function was developed to have an alternating
amplitude of0.003 MPa around the mean blood pressure of0.013 MPa.

f ( x) = 0.003sin ( x) + 0.013

(49)

The sinusoidal function was expanded using a Fourier series. The Fourier
series expansion is defined below (Simulia).
N

a= A + Ian cos( nw )(t-t + bn sin( nw )(t-t
0 )

0

n=l

Where:

0 )

(50)
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a is the Fourier expansion

Ao, An, and Bn are Fourier coefficients
I and to are time values
The Fourier series coefficients were calculated to define the initial and
maximum amplitude of the blood pressure curve.

1 2H
an=- f(x)cos(nx)dx

f

(51)

ff 0

1 2H

bn

=-

f f(x)sin(nx)dx

(52)

ff 0

An n value of one was used in order to create one value for an and bn.
1 2H

an=-

f( 0.003sin(x)+0.013)*cos(x)dx = 0

(53)

ff 0

1 2H
bn =- f(o.003sin(x)+0.013)*sin(x)dx=0.003

(54)

ff 0

The Fourier series becomes sinusoidal due to the fact that an is zero. The
cosine terms of the series can be ignored.
N

a= A + L),, sin(nm)(t-1.)
0

(55)

n==I

The Fourier analysis indicated that the blood pressure is purely sinusoidal and
fluctuates around the mean value with an amplitude of 0.003 MPa. Rebelo et al.
found that the pressure can be model using a mean value of 0 MPa with amplitude
fluctuations of0.003 MPa (Rebelo, Fu, & Lawrenchuk, 2008). This remains a purely
sinusoidal loading curve.
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f(x) = 0.003sin(x)

(56)

The Fourier coefficients remain at OMPa and 0.003 MPa, respectively. The
pressure amplitude change from positive to negative indicates that the blood pressure
induces tensile and compressive loading. Perry et al. found that this change from
tension to compression causes the stent to cycle from its expanded major diameter to
a smaller minor diameter (Perry, Oktay, & Muskivitch, 2002).
Perry also found that stent fatigue is primarily determined by the stent
geometry, material strength, and blood pressure loading. Therefore, for the sake of
simplicity, the artery and stent contact can be ignored. This method is
computationally efficient due to the elimination of contact matrix iterations and a
reduction in the number of systems of equations.
Pressure was applied to the inside of the stent as a periodic load using the
above stated Fourier expansion. Translations in the X, Y, and Z axes were
constrained on a node on both the proximal and distal ends of the stent. The
constrained boundary conditions prevented the stents from rotating.
A modified Goodman failure criterion is generally used for stent finite life
assessment. The Modified Goodman criterion is summarized in equation 57.
(J"a

ae

Where:

cra is the alternating stress
cr. is the material endurance strength

+

(J"m

auts

=[

(57)
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crm is the mean stress
cruis

is the material ultimate tensile strength
Stress life theory was used to determine the number of reversible cycles of the

316L stainless steel stents. Stress life theory expands on the Modified Goodman
theory by taking stress amplitude and the material's ultimate tensile strength into
account when determining the cycle to failure.
(58)
Equation 58 was used to solve the number ofreversible loads until stent
failure.
a=

(JS",)'
S,

(59)

(60)

(61)

(62)

S,

= 0.5S""

(63)

The UTS value for 316L stainless steel was calculated to be 474 MPa
(Bargiggia, 2008). The fatigue strength fraction (fJ was determined to be 0.9 due to
the material's ultimate tensile strength. The material's endurance strength (S,) is half
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of the ultimate tensile strength or 242.5 MPa. The 'a' value was calculated to be
776.099 MPa. The 'b' value was calculated to -0.085091 for 3!6L stainless steel.
The maximum principle stress at the beginning of the fatigue loading and the
minimum principle stress at the end of the fatigue loading step were analyzed to
determine the stress amplitude. Table 8 contains the stress amplitude for the 316L
stainless steel stents.
Table 8

Stress Amplitude for 3 l 6L Stainless Steel Stents (MPa)
Stent Design Replicate 1 Replicate 2

A

562.0

514.5

B

123.5

122.8

C

164.8

124.4
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Figure 28. Stent a stress; (a) max imum principle stresse (replicate I), (b) minimum
principle stress (replicate I). (c) max imum principle stre ses (replicate 2). and (d)
min imum pri nciple stress (replicate 2)
Figure 28 shows that the stresses in stent A with 3 16L stainless steel as the
material are evenly di stributed throughout the entire stent. It is hy pothesized that
crack initiali zation could occur at any point w ithin the stent. This wide pread crack
initia lization could possibly lead to widespread crack propagation and total stent
fa ilure. Widespread crack propagation wou ld most likely lead to a loss of stent hoop
strength and stent co llapse. lt also shows a significant change in stent diameter. This
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cou ld possibly be caused by the thin nature of the stru ts which lead to a smaller
section modulus and higher detlection.
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Figure 29. Stent b stress; (a) max imum principle stresses (repl icate 1), (b) min imum
principle stresses (replicate I), (c) max imum principle stresses (replicate 2), and (d)
minimum princip le stresses (replicate 2)
Figure 29 shows stent B with 3 l 6L stainles

teel at the material. Stre se are

concentrated along the inside of the struts. Stresses are also localized around the strut
and bridge connection. lt can be safely assumed that crack initialization would occur
at the localized stress regions. The stru t and bridge interface are stres concentrati on
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poin ts due to sharp comers produced from the transition from bridge

LO

strut. This

figure also shows relatively low stresses in the struts that are not adjacent to the
bridges which lead to the viabi lity of open stent designs. The struts would be able to
maintain radial strength due to the low stresses in the struts.
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(d)

Figure 30.Stent C stress; (a) maximum pri nciple stresses (replicate I), (b) minimum
principle Stresses (replicate I), (c) maximum princip le stresses (replicate 2), and (d)
minimum principle stresses (replicate 2)
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Figure 30 shows the stresses for stent c with 316L stainless steel as the
material. Stresses are concentrated at the strut and bridge transition (similar to that of
stent B). Crack initialization is hypothesized to begin at the transition.
Table 9 shows the fatigue life for the 3 l 6L stainless steel stents.
Table 9
Fatigue for 316L Stainless Steel Stents (number of cycles)

Stent Design Replicate 1 Replicate 2

A

44.4

125.3

B

2.4* 109

2.6*10 9

C

8.0* I 07

2.2*10 9

Nitinol exhibited low principle stresses during expansion and fatigue loading
due to its stress/strain recovery. Therefore, strain life theory is suitable for accurately
determining the finite life cycle of a Nitinol stent (Runciman, Xu, Pelton, & Ritchie,
2011).

(64)
Where:
t;.e/2 is the strain amplitude

N is the cycles until failure
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Table IO contains the strain amplitude for the Nitinol stents.
Table JO
Strain Amplitude for Nitinol Stents

Stent Design Replicate 1 Replicate 2
A

5.7*10

5.7*10-

B

2.72*10 4

2.25*104

C

9.1 *10-5

9.1*10-5

The following figures show the strain locations for Nitinol based stents.
These figures begin on the next page.
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(a)

(b)

(c)

(d)

Figure 31. Stent a stra in; (a) maxi mum principle strain (replicate I), (b) minimum
principle strain (replicate I), (c) max imum principle train (replicate 2), and (d)
minimum principle strain (replicate 2)
Figure 3 1 shows the strains for stent A with

itino l as the material. Nitinol

shows di ssimilar results compared to 3 I 6L stainless steel for this stent. The strains
are not uniformly distributed as the stresses were. The

itinol based strains are

located at the connection points between struts. This strain concentration is most
likely due to the sharp transition betv,1een struts. Crack initialization wou ld occur at
these sharp transitions.
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(a)

(b)

(c)

(d)

Figure 32. Stent b strain; (a) maximum princip le strain (replicate 1), (b) rnjn imum
principle strain (replicate l), (c) maximum princip le strain (replicate 2), and (d)
minimum ptinc iple strain (replicate 2)
Figure 32 shows that the strains for stent B ( itinol as the material) are
loca lized on the inside of the struts. These strains would act as crack propagation
points. The high strain amplitude at these points wou ld most likely lead to crack
initialization and ultimately lead to stent fa ilure.
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(a)

Figure 33. Stent C strain; (a) max imum principle strain (replicate l), (b) minimum
p1inciple strain (replicate I), (c) maximum principle strain (replicate 2), and (d)
minimum principle strain (repl icate 2)
Figure 33 shows that the strains for stent C are concentrated around the strut
curvature. Cracks could form at these points.
Table 11 contains the cycles to failure for the Nitinol stents.
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Table 11

Fatigue for Nitinol Stents (number of cycles)

Stent Design Replicate 1 Replicate 2
A

1.2*10

1.2*10

B

5.1*10 10

7.5*10 10

C

4.6* 10 11

4.6*10 11

PLLA was used as a control in this experiment because it has a known
biologically corrosive fatigue life. The human body completely absorbs a PLLA stent
within 24 months of insertion. The number of heart beat cycles until complete
absorption was calculated. Ten years is equal to 380,008,800 heart beat pulse cycles.
Dividing this value by ten yielded a yearly total of38,000,880 cycles. Therefore, 24 months
is the equivalent of7.6*107 cycles.

Statistical Analysis
A 23 factorial design was created in order to understand the significance of
stent design and material selection on fatigue life. The factors for this study were
stent design and material. Different stent designs were stent A, stent B, and stent C.
The different materials were levels of 3 l 6L stainless steel, Nitinol, and PLLA.
Fatigue life was used as the response variable in the study. The study used two
replicates. Table 12 shows the combination table for the factorial design and
replicates.
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Table 12
Factorial Design Combination Table with Response Variable
Material
Stent Desi1m SS316L Nitinol
PLLA
4.4*10' 1.8*10" 7.6*10'
Stent A
l.3*10 2 l.2*10 12 7.6*10 7
2.4*10" 5.1 *10'" 7.6*10'
Stent B
2.6*10 9 7.5*10 10 7.6*10 7
8.0*10' 4.6*10 11 7.6*10'
Stent C
2.2* 109 4.6*10 11 7.6*10 7
An analysis of variance (ANOVA) was used to determine the main effects and

interactions. Table 13 shows the results from the ANOVA testing.
Table 13
ANOVA Outputf,-om Minitab
General Linear Model: Fatigue Life versus Stent Design, Material
Factor

type

Stent Dr:sign
Material

:fiJled
fiaed

Levels Values
3
3

A, B, C
SS316L, Nitinol, PI.IA

?.nalysis of Variance for Fe.tique Life, u:ii.Ilg Adjtl.llted SS for Iests

sow,u
Srent De31;:n

Material
Stent oee1gn•Haterial.

tm,
Tot11l

S • 144.338191246

"

2
2

••

17

S,qSS

.., ss

Adj 115

7.07423[+23

7. 07423[+23

J.5371U:♦23
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'

p

R-Sq(a<1j) • 91.34'

A confidence value of 95% was used to interpret the results. The significance
interval (11) was 0.05 due to the 95% confidence. The p values were compared to the
significance interval. The factor stent design had a p value of0.001. This is less than
the 11 value of0.05. Therefore, the null hypothesis can be rejected and it can be safely
concluded that stent design is an important factor when determining fatigue life. The
significance of stent material was also determined. The factor stent material had a p
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value of0.000. This is also less than the a value. indicating a rejection of the null
hypothesis. Stent material is a sign ificant determinant in fatigue li fe. The interaction
between stent design and material was also analyzed using the p va lue. The
interaction (stent design*material in Table 13) had a p value of0.000. The null
hypothesis was rejected and the interaction is ignificant.
An analy is of residuals and normali ty showed that the data is not normally
distributed. A OVA is based upon the assumption that the residuals are nom1ally
distributed. Therefore. the aforementioned null hypothesis rejections may not be
reliable.
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Figure 34. Normal probabi lity plot versus residuals.
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Versus Fits
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Figure 35. Fits versus residuals.
The non-nonnality in the data was caused by the constant con-osive fatigue
li fe of PLLA. Mechanically speaking. PLLA is a poor material choice when
maximizing fatigue life. PLLA does offer biological advantages due to its lowered
restenosis rates. Removing PLLA from the analysis returned the residuals to a
norn1al distribution. The P values were then recalcul ated without PL LA. Table 14
shows the reca lculated ANOVA table.
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Table 14
Recalculated ANOVA Table
General Linear Model: Fatigue Ufe versus Stent Design, Material
Factor

Type

Scent ~111;-n
Mne?:111.1

fb~
flled

lm.111¥81!1
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Valuell

3 A, B, C
2 llit1nol, SS316L

ot Va.rianee tor htiqu.e l.1.fe, ustng
Dr

'°'"'

Stent Design
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Stellt Oesl1JU•l'.e.tedU

&ro,

,ow

S • 176171459474

'1

''

ll

Seq ss
t.Oi6113U24
1.32891£+24
1.06807!+24
1.87502£+23
J.64562£+24

R-Sq • 94.e6t

Ad)u!lted ss
AdJ SS

tot te11tii

"'' "'

1.on1:u:+2t

5.30567£+23

16.98

0.003

1.321!91!+24
1.06807£-+24
l.B7502E+23

1.32891?+24
S.J4037£+23
J.12503E+22

42.52
17.09

0.001
0.003

R-Sq(adjJ • 90.571

The p values were then re-analyzed to determine .the significance of the
factors. The re-analysis showed that the p values for the main effects as well as the
interaction were less than the a value. The null hypothesis can be rejected indicating
that the main effects and interactions are significant.
The recalculated probability plots showed normaJly distributed residuals. The
normal distribution indicated model adequacy and that the null hypothesis can be
reliably rejected.
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Figure 36. Recalculated normal probabili ty plot.
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Figure 37. Reca lculated fits versus residuals pl ot.
One goal of any stent design to maximize the fatigue life so that the stent does
not prematurely fa il once the stent is placed in-vivo. The interaction plot presented in
Figure 38 indicated that Nitinol maximizes the fatigue for al l stent design studied.
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However, a single stent design did not independently max imize fa tigue life. Stent A
perfot1lled well using

itinol as a materi al but performed poorly with 3 I 6L stainless

steel as the material. This variance of performance from stent A ind icates that the
design is not a robust design. A robust stent should provide adequate fa tigue
performance utilizing a variety of materials. stent B and stent C provided more
consistent performance util izing both 3 l 6L stainles steel and Nitinol. The
interaction plot shows that stent 8 had a higher fa ti gue life than stent C with 3 16L
stainless steel as the material , whil e stent C had a hi gher fatigue life with 3 16L
stainless stee l.
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Figure 38. Interacti on plot for fatigue life.
A Fisher least significant difference (LSD) analysis was al o performed. The Fisher
LSD method compares the mean of the treatments using one way ANOVA techniques. This
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method is useful in finding the similarities and dissimilarities between treatments of a factor.
Figure 39 shows the Fisher LSD output for stent design.
Stent
Design
A
C
B

N
Mean
4 7.3B82SE+ll
4 2.30170£+11

Grouping
A
A

4

A

32969075000

Figure 39. Fisher LSD grouping for stent designs.
The results of the Fisher LSD for stent design showed that all stent designs are
similar because they belong to the same grouping. Figure 40 shows the Fisher LSD
groupings for the treatments of the material factor.
Hacerial N

Mean

Ilit:inol

6

6.66768E+11

5S316L

6

1208403262

Grouping
A

B

Figure 40. Fisher LSD grouping for materials.
Figure 40 shows that the materials were placed in two distinct groupings. The
difference in grouping indicates that the different material treatments are dissimilar.
This dissimilarity means that one material provides better fatigue performance over
the other. Nitinol provides maximum fatigue life compared to 3161 stainless steel.
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Chapter Five
Summary
In this research, the effects of stent design and material on fatigue life were
analyzed. Combinations of three stent designs (see Chapter IV) and three materials
(3 l 6L stainless steel, Nitinol, and PLLA) were tested using Abaqus® finite element
analysis software. A stent geometry was also created using the parametric design
capabilities of SolidWorks®. The stents models were crimped and then expanded to
add appropriate residual stresses. A sinusoidal fatigue load that was equivalent to
blood pressures was then applied to the stents. The maximum/minimum principle
stresses and maximum/minimum principle strains were analyzed in order to calculate
the fatigue load amplitude. The number of fully reversible loads to failure was
calculated using stress life theory and strain life theory. An analysis of variance was
used to determine the significance of stent design and material on fatigue life.

Conclusion
The ANOVA analysis showed that the stent design, material, and the
interaction between the two are significant determinants of fatigue life. A Fisher LSD
showed that the stent designs produced similar results. The deciding factor in stent
fatigue life is stent material. Stent design only produce moderate changes in fatigue
life while material produced a significant change in fatigue life. Designs need to be
robust so that a variety of materials can be used. For example, if future research
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found that Nitinol was not biologically compatible, a robust stent design would be
able to use 3 l 6L stainless steel with similar fatigue life.
The study found that Nitinol was the best material for maximizing fatigue life.
However, fatigue life is not the only factor in the design of stents. PLLA was found
to have an undesirable fatigue life due to its corrosive fatigue. However, PLLA is an
emerging stent technology because of its favorable biological properties. PLLA may
lead to lower restenosis and in-stent thrombosis. Metallic stents can lead to blood
clots due to the polar attraction between the metal and blood cells (hence drug-eluting
stents were introduced to provide anti-thrombotic agents). PLLA reduces the risk of
blood clots by eliminating the polar attraction. It is thought that the artery will be
completely healed within a few years of stent insertion. Therefore, stents may not
need to be permanent arterial scaffolding. Therefore, PLLA may provide this
advantage over its Nitinol and 316L counterparts.
The study found that material is the most significant factor in determining
fatigue life. However, design is still a very important aspect of a stent's success.
Stents also need a high amount of hoop strength (hoop strength is the stent's
resistance to the circumferential stresses applied to the stent due to arterial loading).
Struts with thicker struts have higher hoop strength (but can also have higher
restenosis rates). Flexibility is also an important aspect of a stent' s success. A stent
must be flexible in order for it to travel on a guide wire through the cardiovascular
tree to the offending artery. Open cell stents similar to Stents B and C were
developed to add flexibility and maintain hoop strength.
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Future Research
This research can be expanded to include further in-vivo simulations. The
artery uhyper subroutine written in this thesis can be expanded to an Abaqus® vumat
subroutine. The vumat subroutine is an Abaqus® explicit code that can be used to
model nonlinear materials. Incorporating the vumat code will allow the stents to be
expanded into an artery model. This thesis used Abaqus® implicit; therefore it was
not possible to accurately solve the contact between the stent and artery. Abaqus®
explicit will be better suited for solving the contact between the two dissimilar
materials. The fatigue analysis can then be performed using in-vivo loading
conditions.
An analysis of restenosis would also be an appropriate future work. The stent
exerts a number of forces on the artery during deployment as well as during blood
pressure cycling. The forces in turn induce stresses within the arterial wall layers.
High stresses in the intimal layer can lead to wall shearing. Smooth muscle cells
accumulate around the tear in attempt to heal the artery. The accumulation of smooth
muscle cells can lead to lumen loss which causes restenosis. FEA can be used to
determine the onset of restenosis in differing stent designs. The stresses within the
artery model can be analyzed after the stent model is deployed. The average stresses
in the artery can be used a determinant of stent compliance. Lower artery stresses
would be an indicator oflow restenosis rates while higher artery stresses would be
indicative of high restenosis rates.
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Appendix A
Stent Design Fisher LSD
One-way ANOVA: Fatigue Life versus Stent Design

Source

DF

ss

MS

F

P

Stent Design 2 l.06113E+24 5.30567E+23 1.85 0.213
Error

9 2.58448E+24 2.87165E+23

Total

11 3.64562E+24

S = 535877572920 R-Sq = 29.11 % R-Sq(adj) = 13.35%

Level N

Mean

StDev

A

4 7.38825E+ll 8.88943E+ll

8

4 32969075000 36541239580

C

4 2.30170E+ll 2.64460E+ll

Individual 95% Cls For Mean Based on Pooled StDev
Level

-+---------+---------+---------+--------
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*

(

A
B

*

(

-+
-5.0E+ll

)

*-----)

(

C

)

+

+

+--------

0 5.00E+l l l.00E+l2

Pooled StDev = 535877572920

Grouping Information Using Fisher Method

Stent
Design N

Mean Grouping

A

4 7.38825E+ll A

C

4 2.30170E+ll A

B

4 32969075000 A

Means that do not share a letter are significantly different.

Fisher 95% Individual Confidence Intervals
All Pairwise Comparisons among Levels of Stent Design

100

Simultaneous confidence level= 88.66%

Stent Design = A subtracted from:

Stent
Design

Lower

Center

Upper

B

-l.56304E+ 12 -7.05856E+ 11 1.51327E+ 11

C

-l.36584E+l2 -5.08655E+l l 3.48528E+l I

Stent
Design

--+·---+----+---------+-------

(-----------*----)

B

(---*---)

C

--+---------+---------+----+-------l.4E+12 -7.0E+ll

0 7.00E+ll

Stent Design = B subtracted from:

Stent
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Design
C

Lower

Center

Upper

-6.59982E+l 1 l.97201E+l 1 l.05438E+12

Stent
Design

--+--+·--+--+-------

C

( - - *---)

--+·--+--+--+-------l.4E+12 -7.0E+l 1

0 7.00E+l 1

Material Fisher LSD

One-way ANOVA: Fatigue Life versus Material

Source

DF

ss

MS

F

P

Material 1 l.3289JE+24 l.3289JE+24 5.74 0.038
Error

JO 2.3167JE+24 2.3167JE+23

Total

11 3.64562E+24

S = 481322062464 R-Sq = 36.45% R-Sq(adj) = 30.10%

102

Level

N

Mean

StDev

Nitinol 6 6.66768E+l l 6.80691E+ 11
SS3 l 6L 6 1208403262 1299836359

Individual 95% Cls For Mean Based on Pooled StDev
Level

-+·--+--+--+--

(----------*---)

Nitinol
SS316L

(-- *---)
-+--+·--+--+--

-4.0E+l l

0 4.00E+ 11 8.00E+ 11

Pooled StDev = 481322062464

Grouping Information Using Fisher Method

Material N

Mean Grouping

Nitinol 6 6.66768E+ 11 A
SS316L

6 1208403262

B

103

Means that do not share a letter are significantly different.

Fisher 95% Individual Confidence Intervals
All Pairwise Comparisons among Levels of Material

Simultaneous confidence level= 95.00%

Material= Nitinol subtracted from:

Lower

Material
SS316L

Center

Upper

-1.28474E+l2 -6.65559E+ll -4.63787E+IO

Material ------+---------+---+---+--SS316L

(---*-----------)

------+

+---+---------+---

-1.0E+l2 -5.0E+ll

0 5.00E+l l
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Appendix B
Appendix C provides a tutorial for using Abaqus 8 · Thi s tutorial shows the
modeling and analysis of the three dimensional a1te1y model using the uhyper
subroutine written in this thes is (see Appendix A for source code).
When first opening Abaqusil , you will see the Start Session window.
~ Start Se.S10n

c,.,.,,., Model O.bbas4!
~ WithStandant/Explicil Model
With CFO Model

Op"" Dat.-.base
-

~ Run Script

St.rt Tutorial

R«ffit Flies

lo. 'Thts,s ,r.stiou<,l'alloue.c.a<
, O 'fhem ..~flrtinol/Job-1.odb

l O·/lhtus/. ?11tmol/Jab ,l odo
! 0 /lh<SII/..JNrtinoVJob-1 o dD
.5. O·/lhws ,,JNrtinol'Job 1.odb
n,; Ab1-qv;. $:~tworc &,111 prochd ot Ow~ ~•IIIMl~COJp.. Proftd(.s.(._ Afr,~

7

~ ~tu. tk.30$'1090. $$Ml.ll.4.. -4CATl,l.wt tndtalil'UOf 1ttf~e:1c,duodt1tAtl; otl ~
!r-tt- J: Of it~ ,-~tdi!ifk-$ #I tM \Jt Vld/o, ofktt C011Mntd

El D~swlt S,,tlftt-,, 2010

~ ~~i:w~~i;!:~w;'~~1~LCJ~ifJt'!1~!,-==~•

z:IMULIA

Figure C I. Start Session Window.
Choose With Standard/Explicit Mode l to start a new analysis. Lt is important
to set a work directory. The work directory is a fo lder where all fil es related to the
analysis are stored. Chose File

➔

Set Work Di rectory. Browse to a fo lder where you

would Iike AbaqusJ! to save the fil es.
Doubl e click on parts (left side browser bar). A Create Part window will
appear. Choose a 3D solid extrusion. The approxi mate shape is 20.

ote that there

105

are no units. It is important to keep track of the units. The units for this tutoria l are
mm and MPa.
~ CR!ate Part
Name Artery
Modehng Space
o 30

20 Planar

Aiosymmdric

Options

Typt

o Ddormablt
OlSOtte ng1d

Analytrcal ng,d

None available

Eulenan
Base Fearure

Shat"'

Type

o Sohd

Extrusion

Sholl
W1re

Revolution

SWttp

Pomt

Approximate s1Ze: 20
( Continue..

I

Canctl

Figure C2. Create Part Window.
Click continue to enter the sketcher. Sketch a circle with an outside diameter
of 5.45 mm and an inside diameter of 4.38 mm. Extrude the circles 32 mm to fonn a
hollow cylinder. The hollow cyli nder must be portioned to form the artery layers. A
central axis must be made to partition the cylinder. Choose Create Datum Axis: Axis
of Cylinder. Click the inside surface of the cy linder to create the datum ax is.
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Figure C3. Create Datum Ax is.
Once the axis is created, the cyli nder can be partitioned to add the artery
layers. We will begin wi th the adventiti a layer. Choose the Create Partiti on icon. A
partition will appear. Choose the Cell option.
~ Create Partition

Type
Edge

Face o Cell

Method
Define cutting plane
Use datum plane

Extend face
Extn,do/Sweep edges
Use n-s,ded patch
Sketch planar partition

Figure C4 . Create Partition.
Choose Sketch Planar Partition. Click on the front face of the cylinder to
create a sketching surface. Next you will be asked to choose an edge. Choose the
outside edge of the cy linder. You will be then taken to the sketcher. Sketch a circle
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with a diameter of S.02 mm. After exiting the sketch, choose Extrude/Sweep Edges
from the Create Partition window. Select the edge that you j ust sketched. Then
choose Extrude Along Path. Choose the datum axis created earlier as the direction.
Repeat these steps to create the media (diameter of 4.64 mm). The intima does not
have to be partitioned, it will be automatically partitioned.
The artery must also be partitioned in order to add appropriate boundary
conditions. Choose Define Cutting plane from the partition window. Select the
entire artery as the cell. Choose no1ma l to edge as the type. Select the outside edge
of the artery. Small yellow circles wi ll appear. Select these to create the partitions.
Create partitions shown in Figure CS.

Figure CS. Partitioned Artery
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The artery wi ll now be meshed. Expand th e part container on the left side bar.
Double click mesh. Choose Seed
➔

➔

Part. Enter a global seed of 0.5. Choose Mesh

Controls. Select the entire artery. Change the technique to sweep and choose

media axis. Choose Mesh

➔

Part to mesh the artery. Choose Mesh

➔

Element Type

and deselect reduced integration.

Figure C6. Artery Mesh.
Materials are now created. Choose material from the side bar. A Create
Material Wi ndow wi ll appear. Enter adventiti a as the name. Choose Mechanical ➔
Elasticity

➔

Hyperelastic. Change the strain energy potential to user. Select inc lude

compressibi lity. Repeat this for the media and adventitia.
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N1me: Advffltrua

Descnpt,on:
M1ten,I BehiMOtt

lnput source

• Codftoe:nts

Mo-duft lime: scefe (for vucod1st:1e1tyJ: long•te.rm

:r

✓ lr!ciude c~me1esS<b~

Numbet of property v,lues: 0
The user~defined model only 1ppl.u to A!Hqus/St1nd.trd
•n•~ The user subroubne UHYPER must be:
spectfted 1n the Edit Job d111og

OK

Figure C7. Create Material.
Choo e Section from the side bar. Create a solid section named Adventiti a.
~ Create Secbon
Name: Adventiti;{
Category
1G

Type

Solid

Homogeneous

Shell

Generalized plane strain

Beam

Eulerian
Compo!.ite

Other
Continue...

J

Cancel

Figure C8. Create Section.
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Click continue and change the material to adventitia. Repeat this for the
media and intima. Choose Section Assignment from the expanded part container.
Select the adventitia partions. Assign the adventitia section. Repeat for the media
and intima.
Double click Assembly

➔

Instances on the side bar. Add the artery to the

assembly. Creating an assembly allows for boundary conditions and loads to be
added to the model. Double click BCs on the side bar. Choose
Displacement/Rotation. Choose the partition lines along the X axis. Constrain U2.
Repeat for the Y axis (constrain Ul ).
Double Click Steps from the side bar. Create a static step named tethering.
The NGLEOM option should be selected. Create boundary conditions on the front
face of the artery (change the step to tethering). Set U3 to 8. Create a boundary
condition of U3 equal -8 on the back face. This creates a displacement boundary
condition that will lengthen the artery.
Create a new step named pulse. Select load. Choose pressure. Select the
inside surfaces of the artery (lumen). Enter a value of0.0002 for the magnitude.
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~ Ed1t l ood
Nam~

lo.ad-1

1 ype:

Prenure

Sttp·

Pulse- {Static, Gentr~I)

R«J,o"' (Picked)

I

01str1but1on Unrform

I

7
I:

fix}

M•gn,tude: 0.000.;{
Amplitude

{Rampl

Cancel

Figure C9. Pressure Creation.

Figure C I 0. Boundary Conditi ons and Pressure
Double cl ick Jobs to create an analysis fi le. Under the general tab. find Select
User Subroutine. Browse to the uhyper subroutine. This shows the software where
the material models are located.
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t:: Ed11Job
Name Job-J

I

Model: Mod•I-J

Anatys,< product Abaq~n<Urd

Oescnpt1on:
S..bmiss10n

Gon..al ~ Memory ] Poralldoulion

I Preoo,on

Pre-processor Pnntout
Print an Kho of tht input CUI•

Pnnt contact constra,nt data
Pnnt model df!f1n1bon data
Print history datl

Scratch d1rKtory

Us.er subroutine file:

[3

0:\ Thes,s\Abaqus Tnals\ Arte,y S..broubn• Testmg ,Quort.. Model\subrout,ne comp,

Figure C I I. Edit Job Window.
Right click on the job you j ust created and choose submit. Abaqus-"- will now
perfonn the analysis. After the analysis completes. right click on the job aga in and
choose results to view the results.

